Janney Montgomery Scott LLC Summit Therapeutics Inc. Transaction History
Janney Montgomery Scott LLC
- $36.1 Billion
- Q4 2024
A detailed history of Janney Montgomery Scott LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 15,716 shares of SMMT stock, worth $367,597. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,716
Previous 11,273
39.41%
Holding current value
$367,597
Previous $247,000
13.36%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
198Shares Held
75.9MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$571 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$256 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$185 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$127 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$81.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.71B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...